Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether caudal dexmedetomidine can prevent sevoflurane-induced emergence agitation in children after anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caudal dexmedetomidine (dexmedetomidine)

Snippet

Sponsor: Suez Canal University | Conditions: Delayed Emergence From Anesthesia | Phase 4 | Status: COMPLETED